Altogether, these observations highlight the crucial role of STAP-2 in BRK-mediated STAT3 activation and tumor cell growth and propose this molecule as a potential therapeutic target and prognostic factor for breast cancer patients. Here, PTK6 is linked to breast carcinoma.